Clinical Trials Directory

Trials / Completed

CompletedNCT06812000

Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy

Investigation of Incidence Rate of Post-stroke Seizure and Post-stroke Epilepsy in Patients Under Treatment With Alteplase and Correlated Factors

Status
Completed
Phase
Study type
Observational
Enrollment
199 (actual)
Sponsor
Mazandaran University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This retrospective cohort study was conducted by reviewing the records of consecutive patients referred to Bu Ali Sina Hospital from 2016 to 2023, who were hospitalized with a diagnosis of ischemic stroke. The records of all patients treated with intravenous alteplase during the above period were extracted, and the relevant characteristics were recorded in a questionnaire. In each year, patients with ischemic stroke who were not treated with alteplase but were hospitalized at the Bu Ali Center were selected in a similar number to patients who received alteplase in the same year, and the relevant information was extracted from their records and recorded in a questionnaire. The incidence of post-stroke seizures and epilepsy was determined in both groups, and the factors associated with their incidence were studied and compared.

Conditions

Timeline

Start date
2024-04-14
Primary completion
2025-01-12
Completion
2025-01-12
First posted
2025-02-06
Last updated
2025-02-06

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT06812000. Inclusion in this directory is not an endorsement.

Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy (NCT06812000) · Clinical Trials Directory